Open AccessP23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR‐T CELL THERAPY.
Author(s) -
Fazio F,
Di Rocco A,
Za T,
Tomarchio V,
Rago A,
Piciocchi A,
Caravita di Toritto T,
Annibali O,
De Stefano V,
Foà R,
Martelli M,
Petrucci MT
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829664.02846.2b
Subject(s) - medicine , multiple myeloma , oncology , cohort , refractory (planetary science) , lenalidomide , clinical trial , chimeric antigen receptor , immunotherapy , cancer , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom